Today, the U.S. Food and Drug Administration conditionally approved Exzolt Cattle-CA1 (fluralaner) topical solution for the ...
14h
FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions
The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...
Conditional approval extended through December 2026 for the treatment of CID in dogs CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA’s June deadline – 51 dogs ...
“FDA is doing a thorough investigation, across multiple age groups, of deaths potentially related to coronavirus vaccines,” ...
UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing* First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and anti-MuSK ...
Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
A recent preemption decision out of the Southern District of New York offers encouraging news for medical device ...
Opinion
19hOpinion
Hope for PDCD Foundation Delivers Petition to FDA Urging Approval of the First Targeted PDCD Treatment
The FDA declined to approve a targeted treatment for PDCD – sodium dichloroacetate (DCA) – in September 2025 despite encouraging clinical evidence and the voices of PDCD families reinforcing the ...
The FDA’s approval of Waskyra marks a historic breakthrough in treating Wiskott–Aldrich syndrome, a rare and life-threatening ...
Danish pharmaceutical company, Novo Nordisk, has launched its successful diabetes and weight-loss drug, Ozempic, in India ...
Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, on Dec. 4 announced the Food and Drug Administration ...
CorMedix surges on strong DefenCath uptake as sales climb while the Melinta acquisition expands and diversifies its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback